When assessed, the percentage of PCa patients with UBUs ranged from 11.6 to 71.7% for [18F]PSMA-1007 [18–22, 24, 28–30], from 0 to 23.9% for [68Ga]Ga-PSMA-11 [16, 18, 21, 24, 29], and was 19.8% for the single study using [18F]DCFPyl [26]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.